Local Cervical Immunity in Women with Low-grade Squamous Intraepithelial Lesions and Immune Responses After Abrasion |
Ekalaksananan, Tipaya
(Department of Microbiology, Faculty of Medicine, Khon Kaen University)
Malat, Praphatson (Department of Microbiology, Faculty of Medicine, Khon Kaen University) Pientong, Chamsai (Department of Microbiology, Faculty of Medicine, Khon Kaen University) Kongyingyoes, Bunkerd (Department of Pharmacology, Faculty of Medicine, Khon Kaen University) Chumworathayi, Bandit (Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University) Kleebkaow, Pilaiwan (Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University) |
1 | Song SH, Lee JK, Lee NW, et al (2008). Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV). Gynecol Oncol, 108, 543-8. DOI |
2 | Passmore J, Morroni C, Shapiro S, Williamson A-L, Hoffman M (2007). Papanicolaou smears and cervical inflammatory cytokine responses. J Inflamm, 4, 8. DOI |
3 | Poomtavorn Y, Suwannarurk K, Thaweekul Y, Maireang K (2009). Cervical cytologic abnormalities of cervical intraepithelial neoplasia 1 treated with cryotherapy and expectant management during the first year follow-up period. Asian Pac J Cancer Prev, 10, 665-8. |
4 | Saxena U, Sauvaget C, Sankaranarayanan R (2012). Evidencebased screening, early diagnosis and treatment strategy of cervical cancer for national policy in low- resource countries: example of India. Asian Pac J Cancer Prev, 13, 1699-703. DOI |
5 | Spellberg B, Edwards JE (2001). Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis, 32, 76-102. DOI ScienceOn |
6 | Tjiong MY, van der Vange N, ter Schegget JS, et al (2001). Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine, 14, 357-60. DOI ScienceOn |
7 | Winer RL, Hughes JP, Feng Q, et al (2011). Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomarkers Prev, 20, 699-707. DOI |
8 | Zhao YH, Wang T, Yu GF, et al (2013). Anti-proliferation effects of interferon-gamma on gastric cancer cells. Asian Pac J Cancer Prev, 14, 5513-8. 과학기술학회마을 DOI ScienceOn |
9 | Kim HJ, Kim SY, Lim SJ, et al (2010). One-step chromatographic purification of human papillomavirus type 16 L1 protein from< i> Saccharomyces cerevisiae. Protein Express Purif, 70, 68-74. DOI ScienceOn |
10 | El-Sherif AM, Seth R, Tighe PJ, Jenkins D (2001). Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J Pathol, 195, 179-85. DOI |
11 | Jacob M, Broekhuizen F, Castro W, Sellors J (2005). Experience using cryotherapy for treatment of cervical precancerous lesions in low-resource settings. Int J Gynaecol Obstet, 89, 13-20. DOI |
12 | Jaisamrarn U, Castellsague X, Garland SM, et al (2013). Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS One, 8, 79260. DOI |
13 | Moore MA, Tajima K (2004). Cervical cancer in the asian pacific-epidemiology, screening and treatment. Asian Pac J Cancer Prev, 5, 349-61. |
14 | Koshiol J, Lindsay L, Pimenta JM, et al (2008). Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol, 168, 123-37. DOI ScienceOn |
15 | Marais DJ, Constant D, Allan B, et al (2008). Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women. J Clin Microbiol, 46, 732-9. DOI |
16 | Mohanty K, Lowe J (1990). Cryotherapy in the management of histologically diagnosed subclinical human papilloma virus (HPV) infection of the cervix. Brit J Clin Pract, 44, 574-7. |
17 | Onda T, Carter JJ, Koutsky LA, et al (2003). Characterization of IgA response among women with incident HPV 16 infection. Virology, 312, 213-21. DOI |
18 | Boccardo E, Lepique AP, Villa LL (2010). The role of inflammation in HPV carcinogenesis. Carcinogenesis, 31, 1905-12. DOI ScienceOn |
19 | Amador-Molina A, Hernandez-Valencia JF, Lamoyi E, Contreras-Paredes A, Lizano M (2013). Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses, 5, 2624-42. DOI |
20 | Bais AG, Beckmann I, Ewing PC, et al (2007). Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls. Mediators Inflamm, 2007, 24147. |
21 | Dwivedi S, Goel A, Natu SM, et al (2011). Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced prostate cancer: a prospective study. Asian Pac J Cancer Prev, 12, 1843-8. |
22 | Bermudez-Morales VH, Gutierrez LX, Alcocer-Gonzalez JM, Burguete A, Madrid-Marina V (2008). Correlation between IL-10 gene expression and HPV infection in cervical cancer: a mechanism for immune response escape. Cancer Invest, 26, 1037-43. DOI ScienceOn |
23 | Chumworathayi B, Thinkhamrop J, Blumenthal PD, et al (2010). Cryotherapy for HPV clearance in women with biopsyconfirmed cervical low-grade squamous intraepithelial lesions. Int J Gynaecol Obstet, 108, 119-22. DOI |
24 | Clerici M, Ferrario E, Trabattoni D, et al (1997). Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst, 89, 245-50. DOI |
25 | Stanley M (2008). Immunobiology of HPV and HPV vaccines. Gynecol Oncol, 109, 15-21. DOI |